描述 |
Spiramycin 是由链霉菌 (Streptomyces ambofaciens) 产生的临床上重要的 16-元大环内酯类抗生素。 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
靶点 |
Bacterial[1]
|
||||||||||||
溶解度 |
体外:
DMSO:≥100mg / mL(118.62 mM) * “≥”表示可溶,但饱和度未知。 体内:1。逐个添加每种溶剂:10%DMSO 90%玉米油溶解度:≥2.5mg / mL(2.97 mM);澄清溶液2.逐个加入每种溶剂:10%DMSO 90%(20%SBE-β-CD在盐水中)溶解度:≥2.5mg/ mL(2.97mM);澄清溶液3.逐个添加每种溶剂:10%DMSO 40%PEG300 5%吐温-80 45%盐水溶解度:≥2.5mg/ mL(2.97mM);明确解决方案
|
||||||||||||
储备液 |
|
||||||||||||
存储 |
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
O[C@H](C1)[C@H](OC)[C@@H](O[C@H]2[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@](O)(C)C3)[C@@H](C)O2)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@@H]4O[C@H](C)[C@@H](N(C)C)CC4)/C=C/C=C/C[C@@H](C)OC1=O |
||||||||||||
参考文献 |
|
||||||||||||
相关活性 小分子 |
嘌呤霉素盐酸盐 | G-418 硫酸盐 | 衣霉素 | 潮霉素B | 盐霉素 | 阿维巴坦钠 | 硫酸新霉素 | 法硼巴坦 | 甲氧西林钠 | 利福平 | 甲硝唑 | 羧苄青霉素钠 | 头孢他啶 | Eravacycline dihydrochloride | 头孢噻肟钠 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 913.7±65.0 °C at 760 mmHg |
分子式 | C43H74N2O14 |
分子量 | 843.053 |
闪点 | 506.4±34.3 °C |
精确质量 | 842.513977 |
LogP | 3.06 |
蒸汽压 | 0.0±0.6 mmHg at 25°C |
折射率 | 1.550 |
个人防护装备 |
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危害码 (欧洲) |
Xi |
风险声明 (欧洲) |
36/37/38 |
安全声明 (欧洲) |
26-36-24/25 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 1 |
RTECS号 | WG9400000 |
海关编码 | 29419090 |
Regulation of the biosynthesis of the macrolide antibiotic spiramycin in Streptomyces ambofaciens. J. Bacteriol. 192(21) , 5813-21, (2010)
Streptomyces ambofaciens synthesizes the macrolide antibiotic spiramycin. The biosynthetic gene cluster for spiramycin has been characterized for S. ambofaciens. In addition to the regulatory gene srm…
|
|
A spicamycin derivative (KRN5500) provides neuropathic pain relief in patients with advanced cancer: a placebo-controlled, proof-of-concept trial. J. Pain Symptom Manage. 43(4) , 679-93, (2012)
Neuropathic pain in patients with cancer can be difficult to treat effectively.The purpose of the study was to determine safety and efficacy of KRN5500, a novel, spicamycin-derived, nonopioid analgesi…
|
|
Influences of two antibiotic contaminants on the production, release and toxicity of microcystins Ecotoxicol. Environ. Saf. 77 , 79-87, (2012)
The influences of spiramycin and amoxicillin on the algal growth, production and release of target microcystins (MCs), MC-LR, MC-RR and MC-YR, in Microcystis aeruginosa were investigated through the s…
|
|
[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5S,6S)-4,5-Dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-10-{[(2R,5S,6S)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-7-yl]acetaldehyde (non-preferred name) |
Leucomycin |
Foromacidin |
Provamycin |
[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5S,6S)-4,5-Dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-10-{[(2R,5S,6S)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-7-yl]acetaldehyde |
Spiramycin I |
Rovamycin |